AUG 13, 2021 7:30 AM PDT

Breast Cancer Drug Reverses Deadly Blood Cancer in Mice

WRITTEN BY: Annie Lennon

A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The study was published in Cancer Research by scientists at the University of Virginia Health System. 

Myelofibrosis is a form of leukemia- cancer of the blood and bone marrow. It typically occurs in those who are middle-aged or older and affects between 1 and 1.5 in every 100,000 people. Those with advanced stages of the disease have a median survival time of 1.5 to 2.3 years. 

Ruxolitinib, a kinase inhibitor, is used to relieve symptoms of the disease. The drug, however, does not address the disease's characteristic feature, bone marrow scarring. Scarring both disrupts the marrow's production of red blood cells- causing severe anemia- and reduces the number of platelets in the blood, making clotting difficult and enlarging the spleen. 

Previous studies have found that palbociclib, a cyclin-dependent kinase (CDK) inhibitor, reduces activity in the bone marrow of patients with advanced stages of breast cancer. Researchers thus sought to see how patients with myelofibrosis would respond to the drug.

In experiments involving mouse models of myelofibrosis, the researchers showed that palbociclib was able to reduce bone marrow scarring. It also decreased excessive levels of white blood cells and shrank their enlarged spleens. 

They then found that, when combined with ruxolitinib, palbociclib was able to restore bone marrow in mice, normalize white blood cell counts, and further reduce the size of enlarged spleens. 

"A combinatorial therapeutic approach involving palbociclib and ruxolitinib will enable lowering the doses of each of the inhibitors and thus reducing toxicities while enhancing the therapeutic efficacy," wrote the researchers in their paper. 

"The findings from this study are very exciting, and they support the clinical investigation of palbociclib and ruxolitinib combination in patients with myelofibrosis," said Golam Mohi, one of the authors of the paper. 

 

Sources:  Cancer ResearchMPN ConnectScience Daily

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 13, 2022
Neuroscience
Does a High-fat Diet Shrink the Brain?
JUL 13, 2022
Does a High-fat Diet Shrink the Brain?
A study published in Metabolic Brain Disease found an association between high-fat diets and several health diseases. In ...
AUG 12, 2022
Cannabis Sciences
Study Shows Water Soluble CBD Has Better Absorption than Oil-Based CBD Products
AUG 12, 2022
Study Shows Water Soluble CBD Has Better Absorption than Oil-Based CBD Products
Colorado State University researchers examined the pharmacokinetics of cannabidiol (CBD) and its impact on liver functio ...
AUG 17, 2022
Neuroscience
The Research Value of Patient Medical Records and Samples
AUG 17, 2022
The Research Value of Patient Medical Records and Samples
A majority of patients want notification about the potential uses of their medical records or samples according to a stu ...
AUG 27, 2022
Drug Discovery & Development
Universal Vaccine for Influenza A and B Shows Promise in Mice
AUG 27, 2022
Universal Vaccine for Influenza A and B Shows Promise in Mice
A new universal flu vaccine is effective against both influenza A and B viruses in mice. The corresponding study was pub ...
SEP 26, 2022
Immunology
A Rheumatoid Arthritis-Promoting Molecule is Identified
SEP 26, 2022
A Rheumatoid Arthritis-Promoting Molecule is Identified
Researchers have found that a protein called sulfatase-2 may play a significant role in the tissue damage caused by rheu ...
OCT 01, 2022
Drug Discovery & Development
Capsule-based Fecal Microbiota Transplant Treats Clostridiodes Difficile Infection
OCT 01, 2022
Capsule-based Fecal Microbiota Transplant Treats Clostridiodes Difficile Infection
Oral treatment with Fecal Microbiota Transplant (FMT) via capsules containing freeze-dried microbes has similar effects ...
Loading Comments...